
Welcome to The Journal of Cardiovascular Electrophysiology 4.0 onlinelibrary.wiley.com/doi/…

Dedicated to providing the highest quality and most clinically relevant content, showcasing the changing and interconnected world of global electrophysiology.

Welcome to The Journal of Cardiovascular Electrophysiology 4.0 onlinelibrary.wiley.com/doi/…

🕐 Timing matters in AF ablation. Early ablation (≤ 1 year after dx) lowered AF-recurrence risk by 22 % in HFrEF and 17 % in HFpEF, TriNetX multicenter analysis – now in @JCardioEP 🔗pubmed.ncbi.nlm.nih.gov/4118… ✒️@MayoClinicCV @DrDeese99 @abhishek_mbbs @ElBenawiH @M_EISA_2012

EPIC‑BrS: Epicardial ablation sharply reduces VF in malignant Brugada. Adjunctive ablation may outperform ICD-only strategy 🔗 pubmed.ncbi.nlm.nih.gov/4124… ✒️ @LucasMBarbosa01 @OliveiraVMR



🤔 Is LBBAP CRT cost-effective compared with BVP CRT? ✒️ Find out the results in a recent @JCardioEP manuscript by : @jmsanchezmoreno @ManoloMolina8 @ArritmiasGr @hospital_hvn @Cardio_HURS @CorazonHuvr @AGSSurSevilla 🔗 pubmed.ncbi.nlm.nih.gov/4131…

PWI is definitely not appropriate for all patients with persistent AF. It has been shown to be effective in some cases (low/fractionated voltage, high burden of spatiotemporal dispersion) but in select trials without replication. Persistent AF is an area ripe for continued investigation w/ #AI and advanced signal/vector analysis. We will almost certainly find that a ‘tailored’ / individualized approach is better than one size fits all. @VoltaMedical @VektorMedical
PVI+ is the one area where RCTs have been unable to supercede anecdotes – because operator bias is so powerful. Only two randomized trials have shown efficacy beyond PVI (CONVERGE and VENUS), yet only a minority have adopted. And multiple PWI studies show no systematic benefit when applied widely, yet the majority continue to do so in persistent patients. The time is ripe for personalization targeting individual mechanisms, as one size has been proven to not fit all.

PVI+ is the one area where RCTs have been unable to supercede anecdotes – because operator bias is so powerful. Only two randomized trials have shown efficacy beyond PVI (CONVERGE and VENUS), yet only a minority have adopted. And multiple PWI studies show no systematic benefit when applied widely, yet the majority continue to do so in persistent patients. The time is ripe for personalization targeting individual mechanisms, as one size has been proven to not fit all.
What’s the obsession with PWI in AF ablation? It may appear “safe & easy” @drjohnm BUT no randomised evidence & there is downside #TWIC Oct 10

A 72 y.o. man with a CRT-D developed acute HF due to biventricular pacing tachycardia > 100/min. Frequent ventricular ectopics activated ventricular rate stabilisation for rate smoothing which paradoxically worsened heart failure. #Epeeps

🚀New on @JCardioEP 🎓"Adverse Effect of Ventricular Rate Regularization Pacing in Biventricular Cardiac Resynchronization Therapy" by Chu-Pak Lau et al onlinelibrary.wiley.com/doi/…

With cannabis use on the rise, what are the cardiac risks? This large multicenter study reveals cannabis users face higher rates of atrial & ventricular arrhythmias compared to matched controls. #Epeeps

🚀New on @JCardioEP "Cannabis Use and the Risk of Arrhythmias: Insights From a Large Retrospective Multicenter Analysis" by @juanpvf1708 et al onlinelibrary.wiley.com/doi/…


🚀 New in @JCardioEP 📷 "Contemporary Outcomes of Ventricular Tachycardia Ablation in Left Ventricular Assist Device Therapy: A Meta-Analysis" by @TheVash12 et al @Davilandre onlinelibrary.wiley.com/doi/…

New insights in hybrid AF ablation: functional gaps & atrial fibrosis predict early arrhythmia recurrence. High-density mapping helps target completion lesions and improve rhythm success. #Epeeps

📜 Functional Gaps and Atrial Fibrosis as Predictors of Early Arrhythmia Recurrence After Robotic-Enhanced Hybrid Ablation for Persistent Atrial Fibrillation by @EduardoCelenta1 et al @nmsdegroot onlinelibrary.wiley.com/doi/…